Connect with others who understand.

sign up log in
About MyLymphomaTeam

Connect with others who understand.

sign up log in
About MyLymphomaTeam

Oral Therapies for Indolent NHL: Your Doctor Discussion Guide

Posted on August 13, 2020
Article written by
Kelly Crumrin

Treating non-Hodgkin lymphoma (NHL) can be challenging, and so can understanding your treatment options. For indolent (slow-growing) types of NHL, doctors may recommend watchful waiting rather than starting treatment right away. For those with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma (MCL), marginal zone lymphoma (MZL), and Waldenström’s macroglobulinemia (WM), there are several new drugs that have gained approval from the U.S. Food and Drug Administration (FDA) in recent years. Whether you are actively treating your indolent NHL or are still on “watch and wait,” it’s a good time to start a discussion with your doctor about your choices.

Traditional chemotherapy, administered intravenously (by IV) at a cancer treatment center, works by attacking all rapidly growing cells in the body. A newer category of NHL treatment is known as targeted therapy because these drugs target specific proteins on or in cancer cells. All cancer treatments cause side effects, but targeted therapies tend to cause fewer side effects and be more effective than older treatments. Many of the newer targeted therapies are oral and can be taken by mouth at home as a pill or capsule.

If you would like to learn more about oral targeted therapies and whether they may be a good option to treat your indolent NHL, you can use this doctor discussion guide to start a conversation with your health care provider.

Your doctor will explain the risks and benefits of each treatment option and make recommendations, but the decision about how to treat your NHL is ultimately up to you. The best treatment plan is the one you and your doctor agree on after discussing your goals for treatment.

All updates must be accompanied by text or a picture.
Kelly Crumrin is a senior editor at MyHealthTeam and leads the creation of content that educates and empowers people with chronic illnesses. Learn more about her here.

Related articles

By: Robert Preidt, HealthDay Reporter WEDNESDAY, March 27, 2019 (HealthDay News) -- The chances...

Ancestry Matters When Seeking Matched Bone Marrow Donors

By: Robert Preidt, HealthDay Reporter WEDNESDAY, March 27, 2019 (HealthDay News) -- The chances...
By Steven Reinberg, HealthDay Reporter TUESDAY, Jan. 8, 2019 (HealthDay News) -- Over the past 25...

U.S. Cancer Deaths Continue to Decline

By Steven Reinberg, HealthDay Reporter TUESDAY, Jan. 8, 2019 (HealthDay News) -- Over the past 25...

Recent articles

Smoking is linked to an increased risk of lymphoma.Tobacco smoking can damage DNA and weaken the...

Does Smoking Increase Your Risk of Lymphoma?

Smoking is linked to an increased risk of lymphoma.Tobacco smoking can damage DNA and weaken the...
You may choose to make certain lifestyle changes when you receive a lymphoma diagnosis to help...

4 Things To Know About Alcohol and Lymphoma

You may choose to make certain lifestyle changes when you receive a lymphoma diagnosis to help...
Ultrasound is an imaging test used to see real-time images of soft tissues and blood vessels....

How Does Ultrasound Detect Lymphoma?

Ultrasound is an imaging test used to see real-time images of soft tissues and blood vessels....
Burkitt lymphoma is a type of non-Hodgkin lymphoma (NHL) that grows very quickly. People who are...

Understanding Treatments for Burkitt Lymphoma

Burkitt lymphoma is a type of non-Hodgkin lymphoma (NHL) that grows very quickly. People who are...
Primary thyroid lymphoma (PTL) is a rare type of cancer. Also called primary lymphoma of the...

Understanding Primary Thyroid Lymphoma

Primary thyroid lymphoma (PTL) is a rare type of cancer. Also called primary lymphoma of the...
Hepatosplenic T-cell lymphoma (HSTCL) is a type of cancer that affects cells of the immune system...

What You Need To Know About Hepatosplenic T-cell Lymphoma: Symptoms, Treatment, and Prognosis

Hepatosplenic T-cell lymphoma (HSTCL) is a type of cancer that affects cells of the immune system...
MyLymphomaTeam My lymphoma Team

Thank you for subscribing!

Become a member to get even more:

sign up for free

close